Researcher
Yun Shan Goh received her PhD degree from the University of Cambridge (UK), looking at antibody response against invasive Salmonella. She expanded her research focus to examine meningococcal meningitis during her postdoctoral training in the Novartis Vaccine Institute for Global Health, Italy, and Wellcome Trust Sanger Institute, UK, where Goh received a Marie Curie Fellowship.
Since joining the A*STAR Singapore Immunology Network (A*STAR SIgN) and then the A*STAR Infectious Diseases Labs (A*STAR IDL), Goh has been studying humoral protection in malarial and respiratory infections. Leveraging on this knowledge, she has been developing immune assays for host-based diagnostics and studying immune profiles of infected and vaccinated individuals to identify potential correlates of protections for disease management and vaccine development.
Related Articles
Battling the blaze of malarial infection
10 Sep 2026A*STAR researchers discover a new vaccine target for malaria that could offer more durable protection.
Reinforcing frontline defences against variants
14 Nov 2024Antibodies in mucous membranes may be key in protecting against SARS-CoV-2 variants, pointing to the
Putting vaccine booster alternatives to the test
24 May 2023Inactivated COVID-19 vaccines could be an equally potent alternative for people with allergic sensitivities to



